Cargando…

Open challenges in developing digital therapeutics in the United States

Detalles Bibliográficos
Autores principales: Miao, Brenda Y., Arneson, Douglas, Wang, Michelle, Butte, Atul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931293/
https://www.ncbi.nlm.nih.gov/pubmed/36812515
http://dx.doi.org/10.1371/journal.pdig.0000008
_version_ 1784889217268056064
author Miao, Brenda Y.
Arneson, Douglas
Wang, Michelle
Butte, Atul J.
author_facet Miao, Brenda Y.
Arneson, Douglas
Wang, Michelle
Butte, Atul J.
author_sort Miao, Brenda Y.
collection PubMed
description
format Online
Article
Text
id pubmed-9931293
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-99312932023-02-16 Open challenges in developing digital therapeutics in the United States Miao, Brenda Y. Arneson, Douglas Wang, Michelle Butte, Atul J. PLOS Digit Health Opinion Public Library of Science 2022-01-18 /pmc/articles/PMC9931293/ /pubmed/36812515 http://dx.doi.org/10.1371/journal.pdig.0000008 Text en © 2022 Miao et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Opinion
Miao, Brenda Y.
Arneson, Douglas
Wang, Michelle
Butte, Atul J.
Open challenges in developing digital therapeutics in the United States
title Open challenges in developing digital therapeutics in the United States
title_full Open challenges in developing digital therapeutics in the United States
title_fullStr Open challenges in developing digital therapeutics in the United States
title_full_unstemmed Open challenges in developing digital therapeutics in the United States
title_short Open challenges in developing digital therapeutics in the United States
title_sort open challenges in developing digital therapeutics in the united states
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931293/
https://www.ncbi.nlm.nih.gov/pubmed/36812515
http://dx.doi.org/10.1371/journal.pdig.0000008
work_keys_str_mv AT miaobrenday openchallengesindevelopingdigitaltherapeuticsintheunitedstates
AT arnesondouglas openchallengesindevelopingdigitaltherapeuticsintheunitedstates
AT wangmichelle openchallengesindevelopingdigitaltherapeuticsintheunitedstates
AT butteatulj openchallengesindevelopingdigitaltherapeuticsintheunitedstates